ChiCTR-INR-17010350
尚未开始
/
/
/
2017-01-06
/
/
动静脉内瘘狭窄
比較折疊球囊導管血管成形術與傳統球囊導管血管成形術的隨機臨床試驗
比較折疊球囊導管血管成形術與傳統球囊導管血管成形術的隨機臨床試驗
The primary objective is to evaluate at post-operation, 1 month, 6 months and 12 months follow-ups the safety and efficacy of scoring balloon for AV Fistula based on primary patency of target lesions in experimental and control groups.
随机平行对照
治疗新技术
60 patients randomized into 2 groups, 30 in experimental group, 30 in control group
Open label
NA
/
30
/
1990-01-01
1990-01-01
/
Percutaneous Transluminal Angioplasty will performed in end-stage renal failure patients with hemodynamically significant (defined as >50%) stenosis of the autogenous fistula.；
请登录查看- Patient refusing treatment - The reference segment diameter is not suitable for available catheter design - Previous PTA for the same lesion - Associated significant (>50%) central venous stenosis - Multiple significant (>50%) stenosis - The patient is minor (<18 years old) - Previous access thrombectomy - Positive pregnancy test result within 7 days before enrolment - Patient is scheduled for a kidney transplant - Life expectancy <6 months - The patient has a known allergy to heparin, aspirin or other anticoagulant/ antiplatelet therapies - The patient is currently enrolled in another investigational device or drug trial - The patient is currently breast-feeding, pregnant or intends to become pregnant；
请登录查看Princess Margaret Hospital
/
Princess Margaret Hospital的其他临床试验
Consultant, Diagnostic Radiology Department, Princess Margaret Hospital的其他临床试验
最新临床资讯
-
大鹏制药临床III期成功
新药说2026-08-13
-
新一代 EGFR-TKI 首个全球 III 期成功
丁香园 Insight 数据库2026-08-13
-
体外诊断原料网2026-08-13
-
佰傲谷BioValley2026-08-13
-
久有基金2026-08-13
-
重庆宸安生物2026-08-13
-
UmabsDB2026-08-13
-
希格生科2026-08-13
-
bioSeedin柏思荟2026-08-13
-
智飞智讯2026-08-13
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 20 8
-
摩熵咨询 34 28
-
摩熵咨询 20 5
-
颁布机构：四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构：国家医保局 2026-07-31
-
颁布机构：国家药品审评中心（CDE） 2026-07-24
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 35 36
-
摩熵咨询 28 39
-
摩熵咨询 34 18
-
颁布机构：国家市场监督管理总局 2026-08-10
-
颁布机构：国家市场监督管理总局 2026-05-29
-
颁布机构：国家市场监督管理总局 2026-05-29